Cargando…

Human monoclonal antibodies for prophylaxis and therapy of viral infections

Detalles Bibliográficos
Autores principales:	Meulen, Jan ter, Goudsmit, Jaap
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2006
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122673/ http://dx.doi.org/10.1007/978-0-387-31047-3_18

Ejemplares similares

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets
por: ter Meulen, Jan, et al.
Publicado: (2004)

The potential of targeted antibody prophylaxis in SARS outbreak control: A mathematic analysis()
por: Bogaards, Johannes Antonie, et al.
Publicado: (2007)

SARS Coronavirus Spike Protein Expression in HL-CZ Human Promonocytic Cells: Monoclonal Antibody and Cellular Transcriptomic Analyses
por: Narasaraju, T., et al.
Publicado: (2009)

The Application Of Monoclonal Antibodies In The Study Of Viruses
por: Carter, Michael J., et al.
Publicado: (1984)

Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants
por: ter Meulen, Jan, et al.
Publicado: (2006)

Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM(+) Memory B Cells
por: Throsby, Mark, et al.
Publicado: (2008)

The Human Antibody Response Against WNV
por: Throsby, Mark, et al.
Publicado: (2009)

Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies
por: Zhang, Fengwen, et al.
Publicado: (2023)

Engineering monoclonal antibodies for COVID-19 prophylaxis
por: Izadpanah, Amin, et al.
Publicado: (2022)

Antiviral mechanisms of two broad-spectrum monoclonal antibodies for rabies prophylaxis and therapy
por: Zorzan, Maira, et al.
Publicado: (2023)

Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis
por: De Benedictis, Paola, et al.
Publicado: (2016)

Trends in the Development and Approval of Monoclonal Antibodies for Viral Infections
por: Reichert, Janice M.
Publicado: (2012)

Prophylaxis, therapy and prevention of viral respiratory infections
por: Kafetzis, Dimitris A.
Publicado: (2004)

Monoclonal antibodies for prophylactic and therapeutic use against viral infections
por: Both, Leonard, et al.
Publicado: (2013)

Monoclonal antibodies for prophylactic and therapeutic use against viral infections()
por: Both, Leonard, et al.
Publicado: (2013)

Methods to Produce Monoclonal Antibodies for the Prevention and Treatment of Viral Infections
por: Merkuleva, Yu. A., et al.
Publicado: (2022)

Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans
por: Müller, Thomas, et al.
Publicado: (2009)

A broad-spectrum and highly potent human monoclonal antibody cocktail for rabies prophylaxis
por: Kim, Pan Kyeom, et al.
Publicado: (2021)

Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome Coronavirus
por: Sivapalasingam, Sumathi, et al.
Publicado: (2021)

New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets
por: Friesen, Robert H. E., et al.
Publicado: (2010)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies
por: Chao, Tzu-Yuan, et al.
Publicado: (2017)

Monoclonal Antibodies for Pre- and Postexposure Prophylaxis of COVID-19: Review of the Literature
por: Vita, Serena, et al.
Publicado: (2022)

Correction: Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans
por: Müller, Thomas, et al.
Publicado: (2009)

Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation
por: Maertens, Johan, et al.
Publicado: (2020)

Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
por: Mokhtary, Pardis, et al.
Publicado: (2022)

Prophylaxis and therapy of viral infections in pediatric patients treated for malignancy
por: Licciardello, Maria, et al.
Publicado: (2011)

Infection prophylaxis and management of viral infection
por: Clausen, Emily S., et al.
Publicado: (2020)

Human monoclonal anti-protective antigen antibody for the low-dose post-exposure prophylaxis and treatment of Anthrax
por: Tang, Qi, et al.
Publicado: (2018)

The paramount importance of serological surveys of SARS-CoV-2 infection and immunity
por: Goudsmit, Jaap
Publicado: (2020)

It is time anti-CGRP monoclonal antibodies be considered first-line prophylaxis for migraine
por: Kubota, Gabriel Taricani
Publicado: (2022)

Characterization of an Isotype-Dependent Monoclonal Antibody against Linear Neutralizing Epitope Effective for Prophylaxis of Enterovirus 71 Infection
por: Lim, Xiao Fang, et al.
Publicado: (2012)

Autoimmunity to nervous tissue antigens after viral infections
por: Ter Meulen, Volker, et al.
Publicado: (1987)

Monoclonal antibodies for imaging and therapy.
por: Epenetos, A. A., et al.
Publicado: (1989)

Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections
por: Ying, Tianlei, et al.
Publicado: (2015)

Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape
por: Krey, Thomas, et al.
Publicado: (2013)

Monoclonal antibodies for the therapy of cancer
por: Simpson, Andrew, et al.
Publicado: (2014)

Monoclonal Antibodies in Cancer Therapy
por: Zahavi, David, et al.
Publicado: (2020)

Monoclonal antibody-based therapies
por: Shima, Midori
Publicado: (2018)

Breakthrough Gastrointestinal COVID-19 and Intrahost Evolution Consequent to Combination Monoclonal Antibody Prophylaxis( )
por: Beddingfield, Brandon J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m97827igrfd8edmd3060n7g42n